vTv Therapeutics Inc.

NasdaqCM:VTVT Stock Report

Market Cap: US$65.0m

vTv Therapeutics Management

Management criteria checks 0/4

vTv Therapeutics' CEO is Paul Sekhri, appointed in Aug 2022, has a tenure of 1.58 years. total yearly compensation is $2.00M, comprised of 10% salary and 90% bonuses, including company stock and options. directly owns 0.71% of the company’s shares, worth $459.15K. The average tenure of the management team and the board of directors is 1.3 years and 1.6 years respectively.

Key information

Paul Sekhri

Chief executive officer

US$2.0m

Total compensation

CEO salary percentage10.0%
CEO tenure1.6yrs
CEO ownership0.7%
Management average tenure1.3yrs
Board average tenure1.6yrs

Recent management updates

Recent updates

Will vTv Therapeutics (NASDAQ:VTVT) Spend Its Cash Wisely?

May 11
Will vTv Therapeutics (NASDAQ:VTVT) Spend Its Cash Wisely?

vTv Therapeutics GAAP EPS of -$0.04

Aug 16

vTv stock soars 18% on $10M equity investment by CinRx Pharma

Jul 25

We Think vTv Therapeutics (NASDAQ:VTVT) Needs To Drive Business Growth Carefully

Aug 17
We Think vTv Therapeutics (NASDAQ:VTVT) Needs To Drive Business Growth Carefully

The Director of vTv Therapeutics Inc. (NASDAQ:VTVT), Richard Nelson, Just Bought A Few More Shares

Mar 03
The Director of vTv Therapeutics Inc. (NASDAQ:VTVT), Richard Nelson, Just Bought A Few More Shares

vTv Therapeutics inks licensing deal for HPP971, shares up 11%

Dec 15

MacAndrews & Forbes buys 625K shares of vTv Therapeutics

Dec 11

vTv Therapeutics raises $47M via stock purchase agreement

Nov 24

CEO Compensation Analysis

How has Paul Sekhri's remuneration changed compared to vTv Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-US$20m

Sep 30 2023n/an/a

-US$22m

Jun 30 2023n/an/a

-US$19m

Mar 31 2023n/an/a

-US$17m

Dec 31 2022US$2mUS$200k

-US$19m

Compensation vs Market: Paul's total compensation ($USD2.00M) is above average for companies of similar size in the US market ($USD661.05K).

Compensation vs Earnings: Insufficient data to compare Paul's compensation with company performance.


CEO

Paul Sekhri (65 yo)

1.6yrs

Tenure

US$2,001,433

Compensation

Mr. Paul J. Sekhri, M.Sc. is Director at AdhereTech Inc. since February 7, 2024. He serves as Chief Executive Officer, President & Director of vTv Therapeutics Inc. since august 01, 2022. He served as Inde...


Leadership Team

NamePositionTenureCompensationOwnership
Paul Sekhri
CEO, President & Director1.6yrsUS$2.00m0.71%
$ 459.2k
Steven Tuch
Executive VP & CFO1.3yrsUS$800.05kno data
Barry Brown
Chief Accounting Officerno dataUS$434.75kno data
Richard Nelson
Executive VP of Corporate Development & Director1.6yrsUS$547.40k0.062%
$ 40.1k
Carmen Valcarce
Chief Scientific Officer & Executive VPno datano datano data
Vanessa McDade
Chief Administrative Officerno datano datano data
Elizabeth Keiley
Executive VP & General Counsel1.1yrsno datano data
Thomas Strack
Chief Medical Officerless than a yearno datano data

1.3yrs

Average Tenure

57yo

Average Age

Experienced Management: VTVT's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Paul Sekhri
CEO, President & Director1.6yrsUS$2.00m0.71%
$ 459.2k
Richard Nelson
Executive VP of Corporate Development & Director3.3yrsUS$547.40k0.062%
$ 40.1k
Keith Harris
Independent Director1.7yrsUS$41.00k0.026%
$ 16.7k
Srinivas Akkaraju
Directorless than a yearno datano data
Anne Phillips
Directorno datano datano data
Raymond Cheong
Directorless than a yearno datano data
Fahed Al-Marzooqi
Director1.7yrsUS$31.55k0.026%
$ 16.7k

1.6yrs

Average Tenure

55yo

Average Age

Experienced Board: VTVT's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.